Weight | 579.986 g/mol |
---|---|
Formula | C27H30ClNO11 |
Hydrogen Acceptors | 12 |
Hydrogen Donors | 6 |
Aromatic Rings | 2 |
Rotatable Bonds | 5 |
ADM hydrochloride (25316-40-9, 56390-09-1)
Epirubicin · Ellence · Pharmorubicin
Score:
#1217 in Biochemistry
,
#1317 in Physics
,
#3048 in Biology
,
#3813 in Chemistry
"What do you need help with?"
LabBot
- Sigma-Aldrich - Search for ADM hydrochloride
- Fisher Scientific - Search for ADM hydrochloride
- TCI - ADM hydrochloride275.00 - 825.00 USD
- Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2Positive Operable Breast Cancer (Journal of Clinical Oncology, 2005)
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. (Journal of Clinical Oncology, 1997)
- Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. (Journal of Clinical Oncology, 1998)
- Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial (Journal of Clinical Oncology, 2006)
- Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. (Journal of Clinical Oncology, 2002)
- Neoadjuvant Therapy with Paclitaxel followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy and Concurrent Trastuzumab in Human Epidermal Growth Factor Receptor 2Positive Operable Breast Cancer: An Update of the Initial Randomized Study Population and Data of Additional Patients Treated with the Same Regimen (Clinical Cancer Research, 2007)
-
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. - Epirubicin
- Ellence
- Pharmorubicin
- Epirubicin Hydrochloride
- 4' Epi DXR
- NSC 256942
- Farmorubicine
- Farmorubicina
- 4' Epi Adriamycin
- 4'-Epi-Doxorubicin
- EPI cell
- NSC256942
- NSC-256942
- EPIcell
- 4' Epiadriamycin
- IMI 28
- 4' Epi Doxorubicin
- Farmorubicin
- 4'-Epidoxorubicin
- IMI28
- 4' Epidoxorubicin
- 4'-Epi-DXR
- Epilem
- EPI-cell
- 4'-Epi-Adriamycin
- 4'-Epiadriamycin
- IMI-28
-
SMILESCC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl
-
InChIKeyMWWSFMDVAYGXBV-UHFFFAOYSA-N
- Pubchem - ADM hydrochloride
- Wikipedia - epirubicin hydrochloride
Epirubicin is an anthracycline drug used for chemotherapy. It can be used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is marketed by Pfizer under the trade name Ellence in the US and Pharmorubicin or Epirubicin Ebewe elsewhere.
Suppliers
Most-cited Publications
Areas of Application
Safety
Trends
Alternate Names
External Links
Similar Compounds
ADM hydrochloride
(25316-40-9, 56390-09-1)
28 alternate names
3 suppliers
Epirubicin hydrochloride
(25316-40-9, 56390-09-1)
28 alternate names
3 suppliers
Epirubicin hydrochloride
(56390-09-1)
28 alternate names
3 suppliers
DAUNORUBICIN HCL
(23541-50-6)
28 alternate names
3 suppliers
DAUNORUBICIN HYDROCHLORIDE
(71214-33-0, 23541-50-6)
28 alternate names
3 suppliers
daunorubcin hydrochloride
(63950-07-2, 23541-50-6, 67463-64-3)
28 alternate names
3 suppliers
23541-50-6
(23541-50-6)
28 alternate names
3 suppliers
idarubicin hydrochloride
(57852-57-0)
28 alternate names
3 suppliers
neohesperidin dihydrochalcone
(20702-77-6)
28 alternate names
3 suppliers
quercitrin
(522-12-3)
28 alternate names
3 suppliers
naringin
(10236-47-2)
28 alternate names
3 suppliers
METHACYCLINE HYDROCHLORIDE
(3963-95-9)
28 alternate names
3 suppliers
RUBRATOXIN B
(21794-01-4)
28 alternate names
3 suppliers
RUBRATOXIN B
(21794-01-4)
28 alternate names
3 suppliers
RUBRATOXINB
(21794-01-4)
28 alternate names
3 suppliers
RALOXIFENE HYDROCHLORIDE
(82640-04-8)
28 alternate names
3 suppliers
OXYTETRACYCLINE HYDROCHLORIDE
(2058-46-0)
28 alternate names
3 suppliers
TETRACYCLINE HYDROCHLORIDE
(64-75-5)
28 alternate names
3 suppliers
Doxycycline hyclate
(24390-14-5, 10592-13-9)
28 alternate names
3 suppliers
CALOTROPIN
(1986-70-5)
28 alternate names
3 suppliers
RUBRATOXIN A
(22467-31-8)
28 alternate names
3 suppliers
Doxycycline hydrochloride
(24390-14-5, 10592-13-9)
28 alternate names
3 suppliers
Metacycline
(3963-95-9, 914-00-1)
28 alternate names
3 suppliers
oxytetracycline
(79-57-2, 7179-50-2, 2058-46-0)
28 alternate names
3 suppliers
ATOVAQUONE
(94015-53-9, 95233-18-4)
28 alternate names
3 suppliers
demeclocycline
(127-33-3)
28 alternate names
3 suppliers
Convallatoxin
(508-75-8)
28 alternate names
3 suppliers
Convallaotoxin
(5822-57-1)
28 alternate names
3 suppliers
7-Hydroxystaurosporine
(112953-11-4)
28 alternate names
3 suppliers
OCHRATOXIN A
(303-47-9)
28 alternate names
3 suppliers
303-47-9
(303-47-9)
28 alternate names
3 suppliers
doxycycline
(564-25-0)
28 alternate names
3 suppliers
tetracycline
(60-54-8, 64-75-5)
28 alternate names
3 suppliers
ZOLPIDEM TARTRATE
(99294-93-6)
28 alternate names
3 suppliers
MINOCYCLINE HYDROCHLORIDE
(13614-98-7)
28 alternate names
3 suppliers
DEMECLOCYCLINE HYDROCHLORIDE
(64-73-3, 127-33-3)
28 alternate names
3 suppliers
Orphenadrine citrate
(4682-36-4)
28 alternate names
3 suppliers
Physostigmine salicylate
(57-64-7)
28 alternate names
3 suppliers
Validamycin
(37248-47-8)
28 alternate names
3 suppliers
iopamidol
(60166-93-0)
28 alternate names
3 suppliers
SARAFLOXACIN HYDROCHLORIDE
(91296-87-6)
28 alternate names
3 suppliers
CARMINIC ACID
(1390-65-4, 1260-17-9)
28 alternate names
3 suppliers
Carmine
(1390-65-4, 1260-17-9, 1343-78-8)
28 alternate names
3 suppliers
CARMINIC ACID
(1390-65-4, 1260-17-9)
28 alternate names
3 suppliers
82508-31-4
(82508-31-4)
28 alternate names
3 suppliers
Carmine
(1390-65-4, 1260-17-9)
28 alternate names
3 suppliers
Ponceau xylidine
(7481-49-4, 3761-53-3)
28 alternate names
1 safety hazard
3 suppliers
7481-49-4
(7481-49-4, 3761-53-3)
28 alternate names
1 safety hazard
3 suppliers
RHODAMINE 6G
(989-38-8)
28 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
28 alternate names
3 suppliers
64-75-5
(64-75-5)
28 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
28 alternate names
3 suppliers
14930-96-2
(14930-96-2)
28 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
28 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
28 alternate names
3 suppliers
OCHRATOXIN C
(4865-85-4)
28 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
28 alternate names
3 suppliers
Noscapine hydrchloride
(912-60-7)
28 alternate names
3 suppliers
Depo-medrol
(53-36-1)
28 alternate names
3 suppliers
Diethylstilbestrol dipropionate
(37221-14-0, 130-80-3)
28 alternate names
3 suppliers
Phorbol 12,13-dibutyrate
(61557-88-8, 37558-16-0)
28 alternate names
3 suppliers
BAMBUTEROL HYDROCHLORIDE
(81732-46-9)
28 alternate names
3 suppliers
VERATRAMINE
(60-70-8)
28 alternate names
3 suppliers
Pibenzimol
(23491-44-3, 23491-45-4)
28 alternate names
3 suppliers
Methylprednisolone acetate
(53-36-1)
28 alternate names
3 suppliers
Disperse Red 60
(17418-58-5, 70956-30-8, 12223-37-9)
28 alternate names
3 suppliers
Methylprednisolone acetate
(53-36-1)
28 alternate names
3 suppliers
Xanthohumol
(6754-58-1)
28 alternate names
3 suppliers
CAS Directory